[Convulsive and anticonvulsive effects of aliphatic and alicyclic sulfonamides].
D000818:Animals; D000927:Anticonvulsants / Q000494:pharmacology; D001786:Blood Glucose; D002256:Carbonic Anhydrases / Q000378:metabolism; D002490:Central Nervous System / Q000187:drug effects*; D000697:Central Nervous System Stimulants; D008025:Ligases / Q000378:metabolism; D008297:Male; D051379:Mice; D010433:Pentylenetetrazole / Q000633:toxicity; D010634:Phenobarbital / Q000494:pharmacology; D051381:Rats; D012640:Seizures / Q000139:chemically induced; D013331:Strychnine / Q000633:toxicity; D013449:Sulfonamides / Q000633:toxicity*
D000927:Anticonvulsants; D001786:Blood Glucose; D000697:Central Nervous System Stimulants; D013449:Sulfonamides; D002256:Carbonic Anhydrases; D008025:Ligases; D013331:Strychnine; D010433:Pentylenetetrazole; D010634:Phenobarbital
Konvulsive und antikonvulsive Wirkungen von aliphatischen und alizyklischen Sulfonamiden.